Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.

http://www.wikidata.org/entity/Q33829668

about

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.

http://www.wikidata.org/entity/Q33829668

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@ast

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@en

type

label

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@ast

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@en

prefLabel

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@ast

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@en

P1433

Q33829668-2AB32A6C-43AF-4F03-AC4C-A9E45E02DC38

P1476

Q33829668-BBBC04A9-3F32-483B-ADF3-429AEF2BAF77

P2093

Q33829668-009E906A-108B-4C8C-9638-E71542189F22

Q33829668-03CB1588-0E3C-456B-B854-60DDD5B6D8F6

Q33829668-0AEB1BDD-F243-43DD-932D-3923518DD561

Q33829668-1744C99B-8714-4AF4-B67E-92C002268B78

Q33829668-2B664903-B5BE-4649-9C78-3A2B9FB6E3FB

Q33829668-6FCBC83C-0F83-4B0B-ACC8-907AAEEDC9AB

Q33829668-9D10420F-2478-44E4-B23A-A9C800EFCB7D

P275

Q33829668-479F5B31-0907-4E49-A1A2-8E41C9FA0C70

P2860

Q33829668-0626346A-26BA-437B-A651-578A4BD5C92C

Q33829668-1201DB14-92BF-4A0B-A556-AB48954D6BBC

Q33829668-121E5050-1029-4E99-8A35-0DCDECE01C18

Q33829668-193778A1-C31C-4A22-B7F9-809BE3073CFF

Q33829668-20189C52-2C06-440F-AFE2-1ED38CFAD6AF

Q33829668-265CD58E-FDFF-48B7-8669-C927136E235C

Q33829668-2953B409-E30C-4731-9D58-2DB91D1EBD0D

Q33829668-295ABB04-66B3-4602-B261-B6FDC6EC576C

Q33829668-3C9F5803-014F-4D1B-854B-2288DD4C6488

Q33829668-3E157B3E-3751-43A1-9B6F-92E4102A1C64

P304

Q33829668-B1980A75-FD52-4306-9603-0B2420A64EF5

P31

Q33829668-8D73ADDE-268B-4EA8-A81E-D11952D7F439

Q33829668-B055D699-2D48-4ED4-8E26-526F62A70D0D

Q33829668-fd99ecde-3238-46b2-9fec-1b31de8bbd4b

P356

Q33829668-F617BDC7-CE91-4D87-9E45-1001ED80B595

P407

Q33829668-AF3F3091-FFEC-46A5-AE76-FB63CAEDC3A9

P433

Q33829668-B4CF9E7E-938F-4008-ABAA-5EA93F250474

P478

Q33829668-701388C4-F692-441A-8C65-C47F8BDB39C3

P5008

Q33829668-9149374D-D767-4530-BCE4-BEEA31C39D6F

P577

Q33829668-4B29341B-F027-4C14-9266-640224A7DAF2

Q33829668-C0E33338-BE76-463D-A737-088525945BD3

P698

Q33829668-83C6C2EA-9532-4014-AA36-F68F6644FDDD

P921

Q33829668-7F410739-D9D0-44BA-B253-C9B72A0541F4

Q33829668-7FE1A85C-7C5C-4BC4-B82B-813F9F947C69

Q33829668-893B5069-3DF1-4D8C-80E9-6525CBD273D5

Q33829668-A14B82B6-E27A-47CD-9945-EFABC94E2201

Q33829668-CE67DD13-9303-40CE-9C4A-B00FE8081B13

Q33829668-E2AD9EC6-0AAD-4ABE-8813-59FE8C6A446A

Q33829668-E5751A04-9593-49B3-BB36-4F7FA57B6A1D

Q33829668-E5AF2BFB-370B-4357-81A2-EF1C63E65E68

Q33829668-E6A19257-234E-44C5-9606-0E32AF61FABA

Q33829668-E7623CD3-E119-46CF-928C-F959FE22A250

P932

Q33829668-6632BC41-35D5-40CD-B2FE-62C4979E16BC

P356

ONCOTARGET.15972

P1433

P1476

Diagnostic and prognostic valu ...... lung cancer: a meta-analysis.

@en

P2093

Hongchang Shen

http://www.w3.org/2001/XMLSchema#string

Jiajun Du

http://www.w3.org/2001/XMLSchema#string

Keying Che

http://www.w3.org/2001/XMLSchema#string

Lei Cong

http://www.w3.org/2001/XMLSchema#string

Qi Liu

http://www.w3.org/2001/XMLSchema#string

Tiehong Zhang

http://www.w3.org/2001/XMLSchema#string

Wei Dong

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

Liquid biopsies: genotyping circulating tumor DNA

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Cancer statistics, 2016

Measuring the accuracy of diagnostic systems

Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503.

Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.

The diagnostic odds ratio: a single indicator of test performance.

P304

36812-36823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.15972

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28415658

http://www.w3.org/2001/XMLSchema#string

P921

transport protein

genetic variation

proto-oncogene proteins

tumor biomarkers

neoplasm proteins

P932

5482700

http://www.w3.org/2001/XMLSchema#string